Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Strategy toward Kinase-Selective Drug Discovery
Mingzhen Zhang, Yonglan Liu, Hyunbum Jang, et al.
Journal of Chemical Theory and Computation (2023) Vol. 19, Iss. 5, pp. 1615-1628
Open Access | Times Cited: 15

Showing 15 citing articles:

How many kinases are druggable? A review of our current understanding
Brian Anderson, Peter Rosston, Han Wee Ong, et al.
Biochemical Journal (2023) Vol. 480, Iss. 16, pp. 1331-1363
Open Access | Times Cited: 21
Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United States
Robert Roskoski
Pharmacological Research (2023) Vol. 194, pp. 106847-106847
Open Access | Times Cited: 15
The allosteric mechanism of mTOR activation can inform bitopic inhibitor optimization
Yonglan Liu, Mingzhen Zhang, Hyunbum Jang, et al.
Chemical Science (2023) Vol. 15, Iss. 3, pp. 1003-1017
Open Access | Times Cited: 13
The Missing Enzymes: A Call to Update Pharmacological Profiling Practices for Better Drug Safety Assessment
Monika Maciąg, Vardan T. Karamyan
Journal of Medicinal Chemistry (2025)
Open Access
Atlas of the Bacterial Serine-Threonine Kinases expands the functional diversity of the kinome
Brady O’Boyle, Wayland Yeung, Jing Lu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Carbohydrate kinase inhibition: a promising strategy in cancer treatment
Amita Jain, Rudradip Das, Monalisha Giri, et al.
Drug Discovery Today (2025), pp. 104308-104308
Closed Access
Integrating Molecular Dynamics and Machine Learning Algorithms to Predict the Functional Profile of Kinase Ligands
Elena Frasnetti, Ivan Cucchi, Silvia Pavoni, et al.
Journal of Chemical Theory and Computation (2024) Vol. 20, Iss. 20, pp. 9209-9229
Closed Access | Times Cited: 3
Molecular basis for differential recognition of an allosteric inhibitor by receptor tyrosine kinases
Jyoti Verma, Harish Vashisth
Proteins Structure Function and Bioinformatics (2024) Vol. 92, Iss. 8, pp. 905-922
Open Access | Times Cited: 2
Personalizing Therapy Outcomes through Mitogen-Activated Protein Kinase Pathway Inhibition in Non-Small Cell Lung Cancer
Hasan Alsharoh, Paul Chiroi, Ekaterina Isachesku, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1489-1489
Open Access | Times Cited: 2
Cell cycle progression mechanisms: slower cyclin-D/CDK4 activation and faster cyclin-E/CDK2
Wengang Zhang, Yonglan Liu, Hyunbum Jang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
The complex impact of cancer-related missense mutations on the stability and on the biophysical and biochemical properties of MAPK1 and MAPK3 somatic variants
Maria Petrosino, Leonore Novak, Alessandra Pasquo, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Death by a thousand cuts through kinase inhibitor combinations that maximize selectivity and enable rational multitargeting
Ian R Outhwaite, Sukrit Singh, Benedict‐Tilman Berger, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 5
The prospect of substrate-based kinase inhibitors to improve target selectivity and overcome drug resistance
Biswajit Biswas, Yen‐Hua Huang, David J. Craik, et al.
Chemical Science (2024) Vol. 15, Iss. 33, pp. 13130-13147
Open Access | Times Cited: 1
Binding Modalities and Phase-Specific Regulation of Cyclin/Cyclin-Dependent Kinase Complexes in the Cell Cycle
Michael T. Bergman, Wengang Zhang, Yonglan Liu, et al.
The Journal of Physical Chemistry B (2024)
Closed Access | Times Cited: 1
Identification of a Potent CDK8 Inhibitor Using Structure-Based Virtual Screening
Tony Eight Lin, Ching-Hsuan Chou, Yiwen Wu, et al.
Journal of Chemical Information and Modeling (2024) Vol. 65, Iss. 1, pp. 378-389
Open Access
Page 1

Scroll to top